Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inferential is an AI-biotechnology company developing a "reasoning engine" for biological systems to accelerate drug discovery and development. Founded by former leaders from Meta's Fundamental AI Research (FAIR) team who pioneered the ESM protein language models, the company aims to move beyond traditional generative AI by enabling models to reason about biological functions and functional consequences. Their platform leverages large-scale machine learning and transformer architectures to provide interpretable insights into complex biological pathways and molecular interactions. Headquartered in San Francisco, Inferential is focused on industrializing the discovery of novel therapeutics through advanced computational reasoning.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inferential.